Business
BioSpectrum Asia
Alliance Pharma unveils state-of-the-art
bioanalytical lab in Brisbane
1 min |
January 2023
BioSpectrum Asia
Vaxxas raises A$34M to clinicall advance needle-free vaccines
Vaxxas has completed a financing round which raised 23 million A$34 million) in new funds.
1 min |
January 2023
BioSpectrum Asia
Merck, Kelun-Biotech ink $9.3B licensing pact for 7 cancer candidates in China
news about finance
1 min |
January 2023
BioSpectrum Asia
Prejex joins hands with Polybond to make needle-less injections in India
Prejex Inc., a spin-off of Germany-based Prejex GMBH, has entered into an agreement with Polybond, headed by Adit Rathi of Rathi Group to manufacture needleless injections.
1 min |
January 2023
BioSpectrum Asia
Thailand develops
speech recognition AI tech for screening depression
1 min |
January 2023
BioSpectrum Asia
Australian first research
trial to explore use of psychedelics for alcohol use disorder
1 min |
January 2023
BioSpectrum Asia
AstraZeneca India
appoints Dr Sanjeev Panchal as Country President MD
1 min |
January 2023
BioSpectrum Asia
One Health Trust BITS Pilani offer PhD
programme in Data Sciences for global health
1 min |
January 2023
BioSpectrum Asia
NTU Singapore and Imperial College London strengthen ties
Building on their successful collaboration in setting up the Lee Kong Chian School of Medicine LKCMedicine), Nanyang Technological University, Singapore NTU Singapore) and Imperial College London have signed a new strategic university-wide partnership to expand their scope of collaboration across research, education, and innovation and enterprise.
1 min |
January 2023
BioSpectrum Asia
Broad-impact Tech Against AMR Threat
According to one of the most comprehensive studies of antimicrobial resistance AMR), 95 million deaths were associated with including 1.27 million deaths attributed to bacterial AMR in 20109.
4 min |
January 2023
BioSpectrum Asia
Al: Tremendous Potential to Transform Bioprocessing Efficiencies
The biopharmaceutical industry is witnessing unprecedented growth, with a surge in demand for vaccines, monoclonal antibodies mAbs), and advanced modalities including RNA therapeutics, mRNA vaccines, and cell and gene therapies CGTs).
5 min |
January 2023
BioSpectrum Asia
Propelling Genomic Research with Future-Proof Digital Infrastructure
Digital transformation in healthcare has been D at breakneck speed since the outbreak of the COVID-109.
4 min |
January 2023
BioSpectrum Asia
“We are seeing activity within biotherapeutics market in Southeast Asia’
Jason Neo, Director, Marketing J-KOSEA, SCIEX, Singapore
2 min |
January 2023
BioSpectrum Asia
“Our ambition requires us to take long-term view, investing in scale and building unmatched capabilities”
The novel trend in single-cell analysis is revolutionising biological research, unravelling underlying genetic credentials while creating new therapeutic approaches and personalised treatments.
5 min |
January 2023
BioSpectrum Asia
‘Innovations that serve a purpose, paired with a good go-to-market Strategy are attractive for VCs"
Singapore’s health and biomedical landscape constitutes a vibrant pool of innovative medical technology, biotechnology and biopharmaceutical entrepreneurship.
5 min |
January 2023
BioSpectrum Asia
“Crovalimab could potentially become the first global drug originating from Singapore”
There has been explosive growth in the mid- size molecules and therapeutic antibody market as many cancers, autoimmune diseases, metabolic diseases, and infectious diseases have been successfully treated.
4 min |
January 2023
BioSpectrum Asia
New Zealand explores
ways to improve clinical trials
1 min |
January 2023
BioSpectrum Asia
Singapore injects
1M into Global Fund for fighting AIDS, malaria and TB
1 min |
January 2023
BioSpectrum Asia
Japan approves manufacturing and marketing of Adtralza for atopic dermatitis
Denmark-based LEO Pharma A/S, a global leader in medical dermatology, has announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has granted approval for the manufacturing and marketing of Adtralza (tralokinumab) subcutaneous injection
1 min |
January 2023
BioSpectrum Asia
Korea, Singapore strengthen bilateral cooperation over digital health medical devices
South Korean Ministry of Food and Drug Safety (MFDS) recently held a bilateral meeting with the Health Sciences Authority (HSA) of Singapore at Seoul to support the advancement of domestic medical devices into the global market and strengthen bilateral cooperation in the field of digital health medical devices
1 min |
January 2023
BioSpectrum Asia
India Discovers 3 Antiviral Molecules For Treating COVID-19
A team of researchers at Indian Institute of Technology (IIT) Roorkee has identified antiviral molecules that can be used effectively to treat COVID-19 infections.
1 min |
December 2022
BioSpectrum Asia
PerkinElmer launches industry-first readyto-use viral vector assays
PerkinElmer, Inc. has launched ready-to-use Adenoassociated Virus Vectors (AAV) Detection Kits to support researchers working on gene therapies for a variety of serious diseases.
1 min |
December 2022
BioSpectrum Asia
Agilent, Monash University collaborate to build Malaysia Integrated Biology Centre
Agilent Technologies has entered a new strategic partnership with Monash University Malaysia (Monash) to build a Malaysia integrated biology centre
1 min |
December 2022
BioSpectrum Asia
Nikon enters into Indian healthcare sector through microscopy biz
Nikon India has announced its foray into India’s healthcare sector through System Product Microscopy business.
1 min |
December 2022
BioSpectrum Asia
Sartorius enters research partnership with The BASE Facility at University of Queensland
Germany-based Sartorius has entered a research partnership with The BASE Facility at The University of Queensland (UQ), Australia to improve the manufacturing process of nucleic acid products led by the external collaboration group, Separation Separation Technology Marketing team.
1 min |
December 2022
BioSpectrum Asia
Singapore links air polluting particles with cardiac arrests
Small particles in air pollution in Singapore might have caused sudden cardiac arrests in some people who were not in hospital but simply going about their normal lives, according to scientists at Duke-NUS Medical School working with the National Environment Agency (NEA) as part of the PanAsian Resuscitation Outcomes Study (PAROS).
1 min |
December 2022
BioSpectrum Asia
New Zealand explores genomic sequencing to improve newborns' well-being
Researchers from the University of Auckland’s Liggins Institute in New Zealand are about to harness the technology of rapid genome sequencing in the hope of improving the well-being of critically ill newborn babies.
1 min |
December 2022
BioSpectrum Asia
Hong Kong uses novel computation methods to develop COVID-19 hotspot map
A research team led by Hong Kong Baptist University (HKBU) has launched the Hong Kong COVID-19 Hotspot Map which allows the intuitive visualisation of real-time and dynamic geographic distribution of COVID-19 cases in Hong Kong.
1 min |
December 2022
BioSpectrum Asia
Korea designs novel skinattachable auditory sensor
A research team at the Department of Chemical Engineering, Pohang University of Science and Technology (POSTECH), South Korea has developed a skin-attachable microphone sensor that clearly detects voices even in harsh noisy environments.
1 min |
December 2022
BioSpectrum Asia
Kyowa Kirin announces change in leadership position
Kyowa Kirin, a Japan-based Global Specialty Pharmaceutical company, has announced the appointment of Abdul Mullick, President, Kyowa Kirin International (KKI), to a new role in the global organisation, as Vice Chief International Business Officer, reporting to the Global President.
1 min |